FDA Approvals of Novel Drugs Bounce Back in 2023

Published on January 2, 2024

The U.S. Food and Drug Administration approved nearly 50% more novel drugs in 2023 than in 2022, putting it back on pace with historical levels, an improvement analysts and investors said could lead to increased investment in biotech firms. FDA nods for innovative therapies…

Read Full Article (External Site)